Sarcoidosis
Sarcoidosis is a disease characterized by inflammation and abnormal collections of immune cells called granulomas, which can affect various organs including the lungs, lymph nodes, skin, and eyes, often resulting in symptoms like wheezing, coughing, shortness of breath, or more generalized symptoms like fever and arthritis. Although it commonly begins in the lungs or lymph nodes, any organ can be affected, sometimes with only mild or no symptoms.
Health Outcomes
- Altered Immune Response
- Altered Serum Immune Protein Levels
- Altered Systemic Immune Response
- Altered T Cell Migratory Behavior
- Changed Serum Calcium Level
- Elevated Plasma Lysozyme Levels
- Elevated Serum Calcium Levels
- Elevated Serum IFN-γ Levels
- Elevated Serum TNF-α Levels
- Enhanced Immune Response Regulation
- Enhanced Lymphocyte Proliferation
- Improved Cell Adhesion
- Improved Cellular Immunity
- Improved Immune-Related Symptoms
- Improved Inflammation Levels
- Improved Inflammatory Status
- Increased 25(OH)D3 Level
- Increased 25-hydroxyvitamin D Level
- Increased Bioavailable 25-Hydroxyvitamin D Level
- Increased CCL-20 Levels
- Increased Expression of CD206
- Increased IFN-γ Levels
- Increased Immune Activation without Cytotoxicity
- Increased Immune Cell Presence
- Increased Immune Marker Levels
- Increased Immune Response
- Increased Immunosuppressive Cytokine Production
- Increased Inflammatory Cell Counts
- Increased Interferon-Gamma Levels
- Increased Interleukin-10 Levels
- Increased Mucosal Thickness
- Increased Serum Calcium Levels
- Increased Serum Complement 3 (C3) Levels
- Increased Serum IL-10 Levels
- Increased Serum Interferon Gamma Levels
- Increased Serum Lysozyme Levels
- Increased TNF-alpha Levels in Macrophages
- Increased Tolerance to Inflammatory Stimuli
- Increased Tumor Necrosis Factor-Alpha Production by Dendritic Cells
- Increased Vitamin D Level
- Inhibited Autoimmune Activation
- Modulated Cytokine Production
- Modulated Host Immune Response
- Modulated Immune Cell Activity
- Modulated Lymphocyte Populations
- Reduced Cervical Lymphadenopathy
- Reduced Cervical Lymphadenopathy Symptoms
- Reduced Histopathological Damage
- Reduced Inflammatory Effects
- Reduced Inflammatory Infiltrate
- Reduced Inflammatory Markers in Aqueous Humour
- Reduced Inflammatory Pathway Activity
- Reduced Inflammatory Response
- Reduced Inflammatory Response to Inflammatory Stimulus
- Reduced Interferon-Gamma Levels
- Reduced Nodule Size
- Reduced Ocular Inflammation
- Reduced Pro-Inflammatory Cytokine Synthesis
- Reduced Pro-Inflammatory Cytokines
- Reduced Pro-Inflammatory Immune Activity
- Reduced Proinflammatory Cytokines Gene Transcription
- Reduced Pulmonary Fibrosis
- Reduced Systemic Inflammatory Response
- Reduced TNF-alpha Level
- Regulated Immune Cell Proliferation
- Regulated Inflammatory Process
- Stable Systemic Inflammatory Response
- Suppressed Inflammatory Chemokine Secretion